论文信息 - Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma - 字舞流文

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

D. Hose | H. Goldschmidt | A. Jauch | T. Hielscher | J. Dürig | I. Schmidt-Wolf | M. Merz | C. Kunz | A. Seckinger | M. Munder | K. Neben | C. Gerecke | U. Bertsch | J. Hillengass | H. Salwender | M. Raab | E. Mai | K. Weisel | M. Haenel | I. Blau | H. Lindemann | C. Scheid | M. Zeis | B. Schurich | B. Huegle-Doerr